81
Views
0
CrossRef citations to date
0
Altmetric
Review

The clinical role of invasive hemodynamics in the evaluation and treatment of structural heart disease

ORCID Icon & ORCID Icon
Pages 483-499 | Received 30 Mar 2023, Accepted 24 May 2023, Published online: 01 Jun 2023

References

  • d’Arcy JL, Coffey S, Loudon MA, et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE population cohort study. Eur Heart J. 2016 Dec 14;37(47):3515–3522.
  • Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Feb 2;143(5):e72–e227.
  • Nishimura RA, Carabello BA. Hemodynamics in the cardiac catheterization laboratory of the 21st century. Circulation. 2012 May 1;125(17):2138–2150. DOI:10.1161/CIRCULATIONAHA.111.060319.
  • Moscucci M. Grossman & Baim’s cardiac catheterization, angiography, and intervention. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2014.
  • Rihal CS, Raphael CE. Handbook of structural heart interventions. Philadelphia, PA: Elsevier; 2021.
  • Sorajja P, Lim MJ, Kern MJ. Kern’s cardiac catheterization handbook. 7th ed. Philadelphia, PA: Elsevier; 2020.
  • Reddy YNV, El Sabbagh A, Packer D, et al. Evaluation of shortness of breath after atrial fibrillation ablation-Is there a stiff left atrium? Heart Rhythm. 2018 Jun;15(6):930–935.
  • Yang CS, Marshall ES, Fanari Z, et al. Discrepancies between direct catheter and echocardiography-based values in aortic stenosis. Cathet Cardiovasc Intervent. 2016 Feb 15;87(3):488–497.
  • Feldman T, Guerrero M. Invasive hemodynamic versus Doppler echocardiographic assessment of aortic stenosis severity. Cathet Cardiovasc Intervent. 2016 Feb 15;87(3):498–499.
  • Levine RA, Jimoh A, Cape EG, et al. Pressure recovery distal to a stenosis: potential cause of gradient “overestimation” by Doppler echocardiography. J Am Coll Cardiol. 1989 Mar 1;13(3):706–715.
  • Schobel WA, Voelker W, Haase KK, et al. Extent, determinants and clinical importance of pressure recovery in patients with aortic valve stenosis. Eur Heart J. 1999 Sep;20(18):1355–1363.
  • Nishimura RA, Grantham JA, Connolly HM, et al. Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation. 2002 Aug 13;106(7):809–813.
  • Scantlebury DC, Geske JB, Nishimura RA. Limitations of Doppler echocardiography in the evaluation of serial stenoses. Circ Cardiovasc Imaging. 2013 Sep;6(5):850–852.
  • Doorey AJ, Gakhal M, Pasquale MJ. Utilization of a pressure sensor guidewire to measure bileaflet mechanical valve gradients: hemodynamic and echocardiographic sequelae. Catheter Cardiovasc Interv. 2006 Apr;67(4):535–540.
  • Bishu K, Coylewright M, Nishimura R. The role of hemodynamic catheterization in the evaluation of hypertrophic obstructive cardiomyopathy: a case series. Catheter Cardiovasc Interv. 2015 Nov;86(5):903–912.
  • Alkhouli M, Eleid MF, Nishimura RA, et al. The role of invasive hemodynamics in guiding contemporary transcatheter valvular interventions. JACC: Cardiovasc Interv. 2021 Dec 13;14(23):2531–2544. DOI:10.1016/j.jcin.2021.08.072.
  • Hachicha Z, Dumesnil JG, Pibarot P. Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis. J Am Coll Cardiol. 2009 Sep 8;54(11):1003–1011.
  • Eleid MF, Nishimura RA, Borlaug BA, et al. Invasive measures of afterload in low gradient severe aortic stenosis with preserved ejection fraction. Circ Heart Fail. 2013 Jul;6(4):703–710.
  • Little SH, Chan KL, Burwash IG. Impact of blood pressure on the Doppler echocardiographic assessment of severity of aortic stenosis. Heart. 2007 Jul;93(7):848–855.
  • Eleid MF, Nishimura RA, Sorajja P, et al. Systemic hypertension in low-gradient severe aortic stenosis with preserved ejection fraction. Circulation. 2013 Sep 17;128(12):1349–1353.
  • Monin JL, Quere JP, Monchi M, et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation. 2003 Jul 22;108(3):319–324.
  • Lloyd JW, Nishimura RA, Borlaug BA, et al. Hemodynamic response to nitroprusside in patients with low-gradient severe aortic stenosis and preserved ejection fraction. J Am Coll Cardiol. 2017 Sep 12;70(11):1339–1348.
  • El-Sabawi B, Nishimura RA, Guerrero ME, et al. Alcohol septal ablation in patients with concomitant hypertrophic cardiomyopathy and aortic valvular stenosis. Catheter Cardiovasc Interv. 2020 Mar 1;95(4):830–837.
  • Krishnaswamy A, Tuzcu EM, Svensson LG, et al. Combined transcatheter aortic valve replacement and emergent alcohol septal ablation. Circulation. 2013 Oct 29;128(18):e366–8.
  • Edris A, Bartel T, Tuzcu EM, et al. Alcohol septal ablation for outflow tract obstruction after transcatheter aortic and mitral valve replacement. Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1461–1465.
  • Miranda WR, Newman DB, Eleid MF, et al. Mid-cavitary obstruction in hypertrophic cardiomyopathy: diagnostic findings at catheterization. Mayo Clin Proc. 2021 Jun;96(6):1684–1686.
  • Biersmith M, Alston M, Makki N, et al. Comparison of catheterization versus echocardiographic-based gradients in balloon-expandable versus self-expanding transcatheter aortic valve implantation. J Invasive Cardiol. 2022 Jun;34(6):E442–E447.
  • Pislaru SV, Nkomo VT, Sandhu GS. Assessment of prosthetic valve function after TAVR. JACC Cardiovasc Imaging. 2016 Feb;9(2):193–206.
  • Eleid MF, Thomas JD, Nishimura RA. Increased prosthetic valve gradients: abnormal prosthetic function or pressure recovery? Catheter Cardiovasc Interv. 2014 Nov 15;84(6):908–911.
  • Pibarot P, Magne J, Leipsic J, et al. Imaging for predicting and assessing prosthesis-patient mismatch after aortic valve replacement. JACC Cardiovasc Imaging. 2019 Jan;12(1):149–162.
  • Burstow DJ, Nishimura RA, Bailey KR, et al. Continuous wave Doppler echocardiographic measurement of prosthetic valve gradients. A simultaneous Doppler-catheter correlative study. Circulation. 1989 Sep;80(3):504–514.
  • Abbas AE, Mando R, Hanzel G, et al. Invasive versus echocardiographic evaluation of transvalvular gradients immediately post-transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2019 Jul;12(7):e007973.
  • Abbas AE, Mando R, Kadri A, et al. Comparison of transvalvular aortic mean gradients obtained by intraprocedural echocardiography and invasive measurement in balloon and self-expanding transcatheter valves. J Am Heart Assoc. 2021 Oct 5;10(19):e021014. DOI: 10.1161/JAHA.120.021014
  • Khalili H, Pibarot P, Hahn RT, et al. Transvalvular pressure gradients and all-cause mortality following TAVR: a multicenter echocardiographic and invasive registry. JACC: Cardiovasc Interv. 2022 Sep 26;15(18):1837–1848.
  • Ruiz CE, Jelnin V, Kronzon I, et al. Clinical outcomes in patients undergoing percutaneous closure of periprosthetic paravalvular leaks. J Am Coll Cardiol. 2011 Nov 15;58(21):2210–2217.
  • Reddy YNV, Miranda WR, Nishimura RA. Measuring pressure gradients after transcatheter aortic valve implantation: rethinking the Bernoulli principle. J Am Heart Assoc. 2021 Oct 5;10(19):e022515.
  • Niederberger J, Schima H, Maurer G, et al. Importance of pressure recovery for the assessment of aortic stenosis by Doppler ultrasound. Role of aortic size, aortic valve area, and direction of the stenotic jet in vitro. Circulation. 1996 Oct 15;94(8):1934–1940.
  • Reddy YNV, Murgo JP, Nishimura RA. Complexity of defining severe “Stenosis” from mitral annular calcification. Circulation. ;140(7):523–525. DOI: 10.1161/CIRCULATIONAHA.119.040095.
  • Nishimura RA, Rihal CS, Tajik AJ, et al. Accurate measurement of the transmitral gradient in patients with mitral stenosis: a simultaneous catheterization and Doppler echocardiographic study. J Am Coll Cardiol. 1994 Jul;24(1):152–158.
  • Nishimura RA, Vahanian A, Eleid MF, et al. Valvular heart disease 2 mitral valve disease-current management and future challenges. Lancet. 2016 Mar 26;387(10025):1324–1334.
  • Eleid MF, Foley TA, Said SM, et al. Severe mitral annular calcification: multimodality imaging for therapeutic strategies and interventions. JACC Cardiovasc Imaging. 2016 Nov;9(11):1318–1337.
  • Kato N, Padang R, Scott CG, et al. The natural history of severe calcific mitral stenosis. J Am Coll Cardiol. 2020 Jun 23;75(24):3048–3057.
  • Eleid MF, Nishimura RA, Lennon RJ, et al. Left ventricular diastolic dysfunction in patients with mitral stenosis undergoing percutaneous mitral balloon valvotomy. Mayo Clin Proc. 2013 Apr;88(4):337–344.
  • Bertrand PB, Mihos CG, Yucel E. Mitral annular calcification and calcific mitral stenosis: therapeutic challenges and considerations. Curr Treat Options Cardiovasc Med. 2019 Mar 30;21(4):19.
  • Brener MI, Hamandi M, Hong E, et al. Early outcomes following transatrial transcatheter mitral valve replacement in patients with severe mitral annular calcification. J Thorac Cardiovasc Surg. 2022 Aug 20. DOI: 10.1016/j.jtcvs.2022.07.038.
  • Lloyd JW, Joseph TA, Cabalka AK, et al. Hemodynamic and clinical response to transseptal mitral valve-in-valve and valve-in-ring. Catheter Cardiovasc Interv. 2019 Sep 1;94(3):458–466.
  • Zahr F, Cigarroa JE. Replacing the mitral valve alone does not completely fix the heart! Catheter Cardiovasc Interv. 2019 Sep 1;94(3):467–468.
  • Alkhouli M, Lopez JJ, Mathew V. Transcatheter therapy for severe tricuspid regurgitation: learning to understand the forgotten valve. J Am Coll Cardiol. 2019 Dec 17;74(24):3009–3012.
  • Taramasso M, Benfari G, van der Bijl P, et al. Transcatheter versus medical treatment of patients with symptomatic severe tricuspid regurgitation. J Am Coll Cardiol. 2019 Dec 17;74(24):2998–3008.
  • Neuhold S, Huelsmann M, Pernicka E, et al. Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a long-term observational study. Eur Heart J. 2013 Mar;34(11):844–852.
  • Alqahtani F, Berzingi CO, Aljohani S, et al. Contemporary trends in the use and outcomes of surgical treatment of tricuspid regurgitation. J Am Heart Assoc. 2017 Dec 22;6(12). DOI: 10.1161/JAHA.117.007597.
  • Topilsky Y, Maltais S, Medina Inojosa J, et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging. 2019 Mar;12(3):433–442.
  • Saran N, Dearani JA, Said SM, et al. Long-term outcomes of patients undergoing tricuspid valve surgery dagger. Eur J Cardiothorac Surg. 2019 Nov 1;56(5):950–958.
  • Sisinni A, Taramasso M, Praz F, et al. Concomitant transcatheter edge-to-edge treatment of secondary tricuspid and mitral regurgitation: an expert opinion. JACC: Cardiovasc Interv. 2023 Jan 23;16(2):127–139.
  • Reddy YNV, Alkhouli M, Nishimura RA. Isolated severe tricuspid regurgitation: an unrecognised and undertreated problem of the forgotten valve. Heart. 2021 Mar;107(5):350–352.
  • Nickenig G, Kowalski M, Hausleiter J, et al. Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge MitraClip technique. Circulation. 2017 May 9;135(19):1802–1814.
  • Fam NP, Ho EC, Zahrani M, et al. Transcatheter tricuspid valve repair with the PASCAL system. JACC: Cardiovasc Interv. 2018 Feb 26;11(4):407–408.
  • Nickenig G, Weber M, Lurz P, et al. Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study. Lancet. 2019 Nov 30;394(10213):2002–2011.
  • Kodali S, Hahn RT, Eleid MF, et al. Feasibility study of the transcatheter valve repair system for severe tricuspid regurgitation. J Am Coll Cardiol. 2021 Feb 2;77(4):345–356.
  • Lurz P, Stephan von Bardeleben R, Weber M, et al. Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation. J Am Coll Cardiol. 2021 Jan 26;77(3):229–239.
  • Sorajja P, Whisenant B, Hamid N, et al. Transcatheter repair for patients with tricuspid regurgitation. N Engl J Med. 2023 Mar 4;388(20):1833–1842.
  • Hahn RT, Asch F, Weissman NJ, et al. Impact of tricuspid regurgitation on clinical outcomes: the COAPT trial. J Am Coll Cardiol. 2020 Sep 15;76(11):1305–1314.
  • Kavsur R, Iliadis C, Spieker M, et al. Predictors and prognostic relevance of tricuspid alterations in patients undergoing transcatheter edge-to-edge mitral valve repair. EuroIntervention. 2021 Nov 19;17(10):827–834.
  • Vanderpool RR, Pinsky MR, Naeije R, et al. RV-pulmonary arterial coupling predicts outcome in patients referred for pulmonary hypertension. Heart. 2015 Jan;101(1):37–43.
  • Bosch L, Lam CSP, Gong L, et al. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction. Eur J Heart Fail. 2017 Dec;19(12):1664–1671.
  • Eleid MF, Padang R, Pislaru SV, et al. Effect of transcatheter aortic valve replacement on right ventricular-pulmonary artery coupling. JACC: Cardiovasc Interv. 2019 Nov 11;12(21):2145–2154.
  • Brener MI, Lurz P, Hausleiter J, et al. Right ventricular-pulmonary arterial coupling and afterload reserve in patients undergoing transcatheter tricuspid valve repair. J Am Coll Cardiol. 2022 Feb 8;79(5):448–461.
  • Lurz P, Orban M, Besler C, et al. Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair. Eur Heart J. 2020 Aug 1;41(29):2785–2795.
  • Ozpelit E, Akdeniz B, Ozpelit EM, et al. Impact of severe tricuspid regurgitation on accuracy of echocardiographic pulmonary artery systolic pressure estimation. Echocardiography. 2015 Oct;32(10):1483–1490.
  • Schlotter F, Orban M, Rommel KP, et al. Aetiology-based clinical scenarios predict outcomes of transcatheter edge-to-edge tricuspid valve repair of functional tricuspid regurgitation. Eur J Heart Fail. 2019 Sep;21(9):1117–1125.
  • Stocker TJ, Hertell H, Orban M, et al. Cardiopulmonary hemodynamic profile predicts mortality after transcatheter tricuspid valve repair in chronic heart failure. JACC: Cardiovasc Interv. 2021 Jan 11;14(1):29–38.
  • Andersen MJ, Nishimura RA, Borlaug BA. The hemodynamic basis of exercise intolerance in tricuspid regurgitation. Circ Heart Fail. 2014 Nov;7(6):911–917.
  • Mohananey D, Narayanswami J, Kumar A, et al. Association of a novel hemodynamic index with aortic regurgitation after TAVR with the Edwards SAPIEN valve. JACC: Cardiovasc Interv. 2019 Jun 24;12(12):1194–1195.
  • Vogt JC, Michelena HI, Nishimura RA, et al. Diastolic blood pressure predicts outcomes after aortic paravalvular leak closure. Catheter Cardiovasc Interv. 2021 Jan 1;97(1):E79–E87.
  • Sinning JM, Hammerstingl C, Vasa-Nicotera M, et al. Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. J Am Coll Cardiol. 2012 Mar 27;59(13):1134–1141.
  • Hollriegel R, Woitek F, Stativa R, et al. Hemodynamic assessment of aortic regurgitation after transcatheter aortic valve replacement: the diastolic pressure-time index. JACC: Cardiovasc Interv. 2016 May 23;9(10):1061–1068.
  • Sinning JM, Stundl A, Pingel S, et al. Pre-procedural hemodynamic status improves the discriminatory value of the aortic regurgitation index in patients undergoing transcatheter aortic valve replacement. JACC: Cardiovasc Interv. 2016 Apr 11;9(7):700–711.
  • Feldman T, Kar S, Elmariah S, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol. 2015 Dec 29;66(25):2844–2854.
  • Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018 Dec 13;379(24):2307–2318.
  • Adamo M, Grasso C, Capodanno D, et al. Five-year clinical outcomes after percutaneous edge-to-edge mitral valve repair: insights from the multicenter GRASP-IT registry. Am Heart J. 2019 Nov;217:32–41.
  • Lim DS, Smith RL, Gillam LD, et al. Randomized comparison of transcatheter edge-to-edge repair for degenerative mitral regurgitation in prohibitive surgical risk patients. JACC: Cardiovasc Interv. 2022 Dec 26;15(24):2523–2536.
  • Sorajja P, Vemulapalli S, Feldman T, et al. Outcomes with transcatheter mitral valve repair in the United States: an STS/ACC TVT registry report. J Am Coll Cardiol. 2017 Nov 7;70(19):2315–2327.
  • Lloyd JW, Reeder GS, Rihal CS, et al. Effect of saline administration on left atrial pressure during transcatheter mitral valve repair. Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1427–1432.
  • Chen L, Mantri N, Eng ML, et al. Intraprocedural direct left atrial and wedge pressure correlation during transcatheter mitral valve repair: results from a single center registry. Catheter Cardiovasc Interv. 2019 Jul 1;94(1):165–170.
  • Eleid MF, Sanon S, Reeder GS, et al. Continuous left atrial pressure monitoring during MitraClip: assessing the immediate hemodynamic response. JACC: Cardiovasc Interv. 2015 Jun;8(7):e117–9.
  • Maor E, Raphael CE, Panaich SS, et al. Acute changes in left atrial pressure after MitraClip are associated with improvement in 6-minute walk distance. Circ Cardiovasc Interv. 2017 Apr;10(4):e004856.
  • Silvestry FE, Rodriguez LL, Herrmann HC, et al. Echocardiographic guidance and assessment of percutaneous repair for mitral regurgitation with the evalve MitraClip: lessons learned from EVEREST I. J Am Soc Echocardiogr. 2007 Oct;20(10):1131–1140.
  • Ikenaga H, Yoshida J, Hayashi A, et al. Usefulness of intraprocedural pulmonary venous flow for predicting recurrent mitral regurgitation and clinical outcomes after percutaneous mitral valve repair with the MitraClip. JACC: Cardiovasc Interv. 2019 Jan 28;12(2):140–150.
  • Horstkotte J, Kloeser C, Beucher H, et al. Intraprocedural assessment of mitral regurgitation during the mitraclip procedure: impact of continuous left atrial pressure monitoring. Catheter Cardiovasc Interv. 2016 Dec;88(7):1134–1143.
  • Kuwata S, Taramasso M, Czopak A, et al. Continuous direct left atrial pressure: intraprocedural measurement predicts clinical response following MitraClip therapy. JACC: Cardiovasc Interv. 2019 Jan 28;12(2):127–136.
  • Lazkani M, Sawant AC, Taase A, et al. Left atrial hemodynamics and left ventricular remodeling -predictors of outcomes after Transcatheter mitral valve repair with the MitraClip device. Catheter Cardiovasc Interv. 2019 Jan 1;93(1):128–133.
  • Siegel RJ, Biner S, Rafique AM, et al. The acute hemodynamic effects of MitraClip therapy. J Am Coll Cardiol. 2011 Apr 19;57(16):1658–1665.
  • Lloyd JW, Rihal CS, Eleid MF. Hemodynamics rounds: hemodynamics of mitral valve interventions. Catheter Cardiovasc Interv. 2020 Sep 1;96(3):712–724.
  • Gajjar M, Yadlapati A, Van Assche LMR, et al. Real-time continuous left atrial pressure monitoring during mitral valve repair using the MitraClip NT system: a feasibility study. JACC: Cardiovasc Interv. 2017 Jul 24;10(14):1466–1467.
  • Bednar F, Budesinsky T, Linkova H, et al. Invasive hemodynamic assessment of cardiac output state after MitraClip therapy in nonanaesthetized patients with functional mitral regurgitation. BioMed Res Int. 2016;2016:6296972.
  • El Shaer A, Mahayni A, Simard T, et al. Baseline left atrial pressure predicts mortality following transcatheter edge-to-edge mitral valve repair. JACC: Cardiovasc Interv. 2021 Oct 25;14(20):2306–2308.
  • El Shaer A, Thaden J, Eleid M, et al. Hemodynamic success is an independent predictor of mid-term survival after transcatheter edge-to-edge mitral valve repair. Circ Cardiovasc Interv. 2022 Mar;15(3):e011542.
  • Calvert PA, Northridge DB, Malik IS, et al. Percutaneous device closure of paravalvular leak: combined experience from the United Kingdom and Ireland. Circulation. 2016 Sep 27;134(13):934–944.
  • Eleid M. Interventional management of paravalvular leak. Heart. 2018 Nov;104(21):1797–1802.
  • Sorajja P, Cabalka AK, Hagler DJ, et al. The learning curve in percutaneous repair of paravalvular prosthetic regurgitation: an analysis of 200 cases. JACC: Cardiovasc Interv. 2014 May;7(5):521–529.
  • Millan X, Skaf S, Joseph L, et al. Transcatheter reduction of paravalvular leaks: a systematic review and meta-analysis. Can J Cardiol. 2015 Mar;31(3):260–269.
  • Alkhouli M, Rihal CS, Zack CJ, et al. Transcatheter and surgical management of mitral paravalvular leak: long-term outcomes. JACC: Cardiovasc Interv. 2017 Oct 9;10(19):1946–1956.
  • Alkhouli M, Zack CJ, Sarraf M, et al. Successful percutaneous mitral paravalvular leak closure is associated with improved midterm survival. Circ Cardiovasc Interv. 2017 Dec;10(12):e005730.
  • Sorajja P, Bae R, Lesser JA, et al. Percutaneous repair of paravalvular prosthetic regurgitation: patient selection, techniques and outcomes. Heart. 2015 May;101(9):665–673.
  • Alkhouli M, Sarraf M, Maor E, et al. Techniques and outcomes of percutaneous aortic paravalvular leak closure. JACC: Cardiovasc Interv. 2016 Dec 12;9(23):2416–2426.
  • Spoon DB, Malouf JF, Spoon JN, et al. Mitral paravalvular leak: description and assessment of a novel anatomical method of localization. JACC Cardiovasc Imaging. 2013 Nov;6(11):1212–1214.
  • Lloyd JW, Rihal CS, Reeder GS, et al. Acute invasive hemodynamic effects of percutaneous mitral paravalvular leak closure. Catheter Cardiovasc Interv. 2017 Nov 1;90(5):851–858.
  • Eleid MF, Cabalka AK, Malouf JF, et al. Techniques and outcomes for the treatment of paravalvular leak. Circ Cardiovasc Interv. 2015 Aug;8(8):e001945.
  • Maor E, Raphael CE, Panaich SS, et al. Left atrial pressure and predictors of survival after percutaneous mitral paravalvular leak closure. Catheter Cardiovasc Interv. 2017 Nov 1;90(5):861–869.
  • Eleid MF, Whisenant BK, Cabalka AK, et al. Early outcomes of percutaneous transvenous transseptal transcatheter valve implantation in failed bioprosthetic mitral valves, ring annuloplasty, and severe mitral annular calcification. JACC: Cardiovasc Interv. 2017 Oct 9;10(19):1932–1942.
  • Muller DWM, Farivar RS, Jansz P, et al. Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation: a global feasibility trial. J Am Coll Cardiol. 2017 Jan 31;69(4):381–391.
  • El Sabbagh A, Eleid MF, Foley TA, et al. Direct transatrial implantation of balloon-expandable valve for mitral stenosis with severe annular calcifications: early experience and lessons learned. Eur J Cardiothorac Surg. 2018 Jan 1;53(1):162–169.
  • Alperi A, Granada JF, Bernier M, et al. Current status and future prospects of transcatheter mitral valve replacement: JACC state-of-the-art review. J Am Coll Cardiol. 2021 Jun 22;77(24):3058–3078.
  • Kamioka N, Babaliaros V, Morse MA, et al. Comparison of clinical and echocardiographic outcomes after surgical redo mitral valve replacement and transcatheter mitral valve-in-valve therapy. JACC: Cardiovasc Interv. 2018 Jun 25;11(12):1131–1138.
  • Whisenant B, Kapadia SR, Eleid MF, et al. One-year outcomes of mitral valve-in-valve using the SAPIEN 3 transcatheter heart valve. JAMA Cardiol. 2020 Nov 1;5(11):1245–1252.
  • Guerrero M, Pursnani A, Narang A, et al. Prospective evaluation of transseptal TMVR for failed surgical bioprostheses: mITRAL trial valve-in-valve arm 1-year outcomes. JACC: Cardiovasc Interv. 2021 Apr 26;14(8):859–872.
  • Eleid MF, Wang DD, Pursnani A, et al. 2-year outcomes of transcatheter mitral valve replacement in patients with annular calcification, rings, and bioprostheses. J Am Coll Cardiol. 2022 Dec 6;80(23):2171–2183.
  • Urena M, Himbert D, Brochet E, et al. Transseptal transcatheter mitral valve replacement using balloon-expandable transcatheter heart valves: a step-by-step approach. JACC: Cardiovasc Interv. 2017 Oct 9;10(19):1905–1919.
  • Eleid MF, Cabalka AK, Williams MR, et al. Percutaneous transvenous transseptal transcatheter valve implantation in failed bioprosthetic mitral valves, ring annuloplasty, and severe mitral annular calcification. JACC: Cardiovasc Interv. 2016 Jun 13;9(11):1161–1174.
  • Misumida N, Guerrero M, Pislaru SV, et al. Hemodynamic response to transseptal transcatheter mitral valve replacement in patients with severe mitral stenosis due to severe mitral annular calcification. Catheter Cardiovasc Interv. 2021 Jun 1;97(7):E992–E1001.
  • Namasivayam M, Feneley MP, Hayward CS, et al. First evaluation of acute left ventricular response to off-pump transcatheter mitral valve replacement in high-risk patients. JACC: Cardiovasc Interv. 2018 Nov 12;11(21):2239–2240.
  • Hungerford S, Bart N, Jansz P, et al. Improved right ventricular function following transapical transcatheter mitral valve implantation for severe mitral regurgitation. Int J Cardiol Heart Vasc. 2021 Feb;32:100687.
  • Hungerford SL, Dahle G, Duncan A, et al. Peri-procedural management of transcatheter mitral valve replacement in patients with heart failure. Eur J Heart Fail. 2022 Dec 15. DOI:10.1002/ejhf.2758
  • Khan JM, Babaliaros VC, Greenbaum AB, et al. Anterior leaflet laceration to prevent ventricular outflow tract obstruction during transcatheter mitral valve replacement. J Am Coll Cardiol. 2019;73(20):2521–2534.
  • Ben-Shoshan J, Wang DD, Asgar AW. Left ventricular outflow tract obstruction: a potential obstacle for transcatheter mitral valve therapy. Interv Cardiol Clin. 2019 Jul;8(3):269–278.
  • Guerrero ME, Killu AM, Gonzalez-Quesada C, et al. Pre-emptive radiofrequency septal ablation to decrease the risk of left ventricular outflow tract obstruction after TMVR. JACC: Cardiovasc Interv. 2020 May 11;13(9):1129–1132.
  • Wang DD, Guerrero M, Eng MH, et al. Alcohol septal ablation to prevent left ventricular outflow tract obstruction during transcatheter mitral valve replacement: first-in-man study. JACC: Cardiovasc Interv. 2019 Jul 8;12(13):1268–1279.
  • Guerrero M, Wang DD, Himbert D, et al. Short-term results of alcohol septal ablation as a bail-out strategy to treat severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement in patients with severe mitral annular calcification. Catheter Cardiovasc Interv. 2017 Dec 1;90(7):1220–1226.
  • Lisko JC, Babaliaros VC, Khan JM, et al. Tip-to-base LAMPOON for transcatheter mitral valve replacement with a protected mitral annulus. JACC: Cardiovasc Interv. 2021 Mar 8;14(5):541–550.
  • Al-Hijji MA, El Sabbagh A, Guerrero ME, et al. Paravalvular leak repair after balloon-expandable transcatheter mitral valve implantation in mitral annular calcification: early experience and lessons learned. Catheter Cardiovasc Interv. 2019 Nov 1;94(5):764–772.
  • Mahowald MK, Nishimura RA, Pislaru SV, et al. Reduction in right atrial pressures is associated with hemodynamic improvements after transcatheter edge-to-edge repair of the tricuspid valve. Circ Cardiovasc Interv. 2021 Dec;14(12):e010557.
  • Howard JP, Cook CM, van de Hoef TP, et al. Artificial intelligence for aortic pressure waveform analysis during coronary angiography: machine learning for patient safety. JACC: Cardiovasc Interv. 2019 Oct 28;12(20):2093–2101.
  • Nedadur R, Wang B, Tsang W. Artificial intelligence for the echocardiographic assessment of valvular heart disease. Heart. 2022 Sep 26;108(20):1592–1599.
  • Bikia V, Papaioannou TG, Pagoulatou S, et al. Noninvasive estimation of aortic hemodynamics and cardiac contractility using machine learning. Sci Rep. 2020 Sep 14;10(1):15015.
  • Esposito C, Machado P, McDonald ME, et al. Noninvasive evaluation of cardiac chamber pressures using subharmonic-aided pressure estimation with definity microbubbles. JACC Cardiovasc Imaging. 2023 Feb;16(2):224–235.
  • Feng S, Wu F, Pan X. Computational fluid dynamics as a novel method to predict haemodynamic changes and guide transcatheter edge-to-edge repair. Eur Heart J. 2023 Apr 26;ehad244. DOI:10.1093/eurheartj/ehad244

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.